Trump-Xi Summit Sparks Renewed Hope for Americans Detained in China 
AWS Data Center Overheating Disrupts Cloud Services in Northern Virginia 
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma 
Morgan Stanley Bets on Optical Component Stocks in Greater China Tech Sector 
Democratic Attorneys General Sue Trump Administration Over CDC Childhood Vaccine Schedule Changes 
CSL Shares Crash as Profit Warning and $5 Billion Impairment Shake Investors 
Why the future of marijuana legalization remains hazy despite high public support 
Is dark chocolate healthier than milk chocolate? 2 dietitians explain 
Novo Nordisk Raises 2026 Outlook on Strong Wegovy Demand 
Orsted Q1 EBITDA Beats Expectations Despite U.S. Impairments 
Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
Trump Administration Seeks Court Pause to Reinstate 10% Global Tariffs 
Trump and IRS in Settlement Talks Over $10 Billion Tax Return Leak Lawsuit 
AI-Driven Inflation Raises U.S. Consumer Prices, Goldman Sachs Says 
Comey Faces Charges Over Instagram Post as Free Speech Debate Intensifies 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Sinaloa Governor Ruben Rocha Denies U.S. Cartel Allegations, Calls Charges Political 
On Monday, a U.S. appeals court ruled in favor of 3M, E.I. du Pont de Nemours and Co, and other manufacturers of "forever chemicals." The court rejected a lower court's ruling, allowing approximately 11.8 million Ohio residents to sue the companies.
Reuters noted that the ruling relieves considerable legal pressure placed on the chemical manufacturers to settle the plaintiffs' claims.
Court Ruling Questions Class Action Suit's Validity
According to Yahoo, Lead plaintiff Kevin Hardwick's complaint against the manufacturers faced scrutiny from the court. The appeals court found his complaint to be overly broad and lacking evidence that the per- and polyfluoroalkyl substances (PFAS) detected in his body could be directly attributed to the defendants.
The court emphasized that the complaint targeted the collective actions of the companies rather than individual responsibility. Notably, the case involved just 10 out of thousands of companies involved in PFAS manufacturing.
The lower court's approval of the class action suit has been vacated, and the court instructed the dismissal of Hardwick's lawsuit. The lawsuit aimed to hold the companies accountable for the health impacts of PFAS exposure and sought to establish a fund to monitor Ohio residents.
Additionally, Hardwick's request for the companies to fund studies on the health effects of PFAS was denied. These forever chemicals, commonly found in consumer products, have been linked to cancer and other diseases.
Robert Bilott, attorney for Hardwick, expressed disappointment with the court's decision. He stated that it contradicts what is known about the history of PFAS manufacturing in the United States. Bilott's legal team is currently evaluating whether to appeal the ruling further.
The Persistence and Prevalence of Forever Chemicals
PFAS substances earned the nickname "forever chemicals" due to their resistance to breaking down in nature or in the human body. The growing number of lawsuits filed against 3M, DuPont, and other manufacturers in recent years reflect concerns over alleged PFAS contamination.
In June, 3M agreed to pay $10.3 billion to settle hundreds of claims regarding public drinking water pollution caused by PFAS. Furthermore, Chemours Co, DuPont de Nemours Inc, and Corteva reached a similar settlement worth $1.19 billion with U.S. water providers.
Photo: 3M News Center
